Hachioji, Japan

Takashi Fukaya

This inventor holds 31 USPTO granted patents and 1 EPO patent, primarily in Surgical Microscopy. Top assignees: Olympus Optical Company, Ltd., Olympus Corporation, Sony Olympus Medical Solutions Inc.. Active years: 1988-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Fukaya. Retrieved from https://idiyas.com/inventor/takashi-fukaya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 90.3


Average Co-Inventor Count = 4.7

ph-index = 20

Forward Citations = 4,000(Granted Patents)


Location History:

  • Ina, JP (1988 - 1989)
  • Hachuouji, JP (1993)
  • Hachiouji, JP (1992 - 1996)
  • Hachioji, JP (1989 - 1998)
  • Sagamihara, JP (1996 - 2006)
  • Tama, JP (2003 - 2012)
  • Tokyo, JP (1997 - 2022)

Company Filing History:


Years Active: 1988-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Microscope Apparatus
Surgical Microscope
Image Observation
Stereomicroscope
Endoscope System
Three-Dimensional Vision
Sterile Instruments Cover
Operating Microscope
Medical Instrument Holding
Position Adjustment
Automatic Control
Variable Magnification
31 patents (USPTO):Explore Patents

Title: The Innovative Mind of Takashi Fukaya: Pioneering Advances in Microscope Technology

Introduction: Takashi Fukaya, a prominent inventor based in Hachioji, Japan, has made significant contributions to the field of optical technology, particularly in the development of innovative microscope apparatuses. With an impressive portfolio of 31 patents, Fukaya's work has enhanced medical imaging and surgical procedures, pushing the boundaries of what is possible in visual diagnostics.

Latest Patents: Among his latest innovations is a groundbreaking microscope apparatus designed for observing the human eye. This sophisticated instrument incorporates a microscope section capable of performing magnified observation while capturing the red reflex from the fundus of the eye. The apparatus includes a holding section to stabilize the microscope and a tilting section that allows for precise adjustments to the illumination and observation optical axes. This innovative design maintains a coaxial state of the optical paths, which is crucial for accurate eye examinations.

Another notable patent in his repertoire is the operation microscope, which integrates an observing and displaying system for operating instruments. This advanced microscope allows for the selective display of endoscopic images and navigation visuals, providing a comprehensive view that includes tomographic and three-dimensional constructed images. Such features facilitate accurate treatment positioning, enhancing the effectiveness of surgical procedures.

Career Highlights: Takashi Fukaya's remarkable career includes significant roles at prestigious companies such as Olympus Optical Company, Ltd. and Olympus Corporation. His experience in these renowned organizations has equipped him with the skills and knowledge to revolutionize optical instruments and improve patient outcomes through innovative technological advancements.

Collaborations: Throughout his career, Fukaya has collaborated with esteemed colleagues in the field, including Masahiko Kinukawa and Hiroshi Fujiwara. These partnerships have fostered a dynamic exchange of ideas and innovation, leading to the successful development of transformative microscope technologies.

Conclusion: Takashi Fukaya stands as a notable figure in the realm of optical innovations. With his extensive patent portfolio and collaborative efforts, he continues to influence the future of medical imaging and surgical practices. His dedication to advancing microscope technology exemplifies the spirit of innovation and the importance of persistent research in improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…